Tyr1 and Ile7 of glucose-dependent insulinotropic polypeptide (GIP) confer differential ligand selectivity toward GIP and glucagon-like peptide-1 receptors

Glucagon like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are incretin hormones released in response to food intake and potentiate insulin secretion from pancreatic β cells through their distinct yet related G protein-coupled receptors, GLP1R and GIPR. While GLP-1 and GI...

Full description

Saved in:
Bibliographic Details
Published inMolecules and cells Vol. 30; no. 2; pp. 149 - 154
Main Authors Moon, Mi Jin, Kim, Hee Young, Kim, Sin Gon, Park, Juri, Choi, Dong Seop, Hwang, Jong-Ik, Seong, Jae Young
Format Journal Article
LanguageEnglish
Published Springer Korean Society for Molecular and Cellular Biology 01.08.2010
한국분자세포생물학회
Subjects
Online AccessGet full text
ISSN1016-8478
0219-1032
DOI10.1007/s10059-010-0100-5

Cover

Loading…
Abstract Glucagon like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are incretin hormones released in response to food intake and potentiate insulin secretion from pancreatic β cells through their distinct yet related G protein-coupled receptors, GLP1R and GIPR. While GLP-1 and GIP exhibit similarity in their N-terminal sequence and overall α-helical structure, GLP-1 does not bind to GIPR and vice versa. To determine which amino acid residues of these peptide ligands are responsible for specific interaction with their respective receptors, we generated mutant GIP in which several GLP-1-specific amino acid residues were substituted for the original amino acids. The potency of the mutant ligands was examined using HEK293 cells transfected with GLP1R or GIPR expression plasmids together with a cAMP-responsive element-driven luciferase (CRE-luc) reporter plasmid. A mutated GIP peptide in which Tyr 1 , Ile 7 , Asp 15 , and His 18 were replaced by His, Thr, Glu, and Ala, respectively, was able to activate both GLP1R and GIPR with moderate potency. Replacing the original Tyr 1 and/or Ile 7 in the N-terminal moiety of this mutant peptide allowed full activation of GIPR but not of GLP1R. However, reintroducing Asp 15 and/or His 18 in the central α-helical region did not significantly alter the ligand potency. These results suggest that Tyr/His 1 and Ile/Thr 7 of GIP/GLP-1 peptides confer differential ligand selectivity toward GIPR and GLP1R.
AbstractList Glucagon like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are incretin hormones released in response to food intake and potentiate insulin secretion from pancreatic beta cells through their distinct yet related G protein-coupled receptors, GLP1R and GIPR. While GLP-1 and GIP exhibit similarity in their N-terminal sequence and overall alpha-helical structure, GLP-1 does not bind to GIPR and vice versa. To determine which amino acid residues of these peptide ligands are responsible for specific interaction with their respective receptors, we generated mutant GIP in which several GLP-1-specific amino acid residues were substituted for the original amino acids. The potency of the mutant ligands was examined using HEK293 cells transfected with GLP1R or GIPR expression plasmids together with a cAMP-responsive element-driven luciferase (CRE-luc) reporter plasmid. A mutated GIP peptide in which Tyr(1), Ile(7), Asp(15), and His(18) were replaced by His, Thr, Glu, and Ala, respectively, was able to activate both GLP1R and GIPR with moderate potency. Replacing the original Tyr(1) and/or Ile(7) in the N-terminal moiety of this mutant peptide allowed full activation of GIPR but not of GLP1R. However, reintroducing Asp(15) and/or His(18) in the central alpha-helical region did not significantly alter the ligand potency. These results suggest that Tyr/His(1) and Ile/Thr(7) of GIP/GLP-1 peptides confer differential ligand selectivity toward GIPR and GLP1R.
Glucagon like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are incretin hormones released in response to food intake and potentiate insulin secretion from pancreatic β cells through their distinct yet related G protein-coupled receptors, GLP1R and GIPR. While GLP-1 and GIP exhibit similarity in their N-terminal sequence and overall α-helical structure, GLP-1 does not bind to GIPR and vice versa. To determine which amino acid residues of these peptide ligands are responsible for specific interaction with their respective receptors, we generated mutant GIP in which several GLP-1-specific amino acid residues were substituted for the original amino acids. The potency of the mutant ligands was examined using HEK293 cells transfected with GLP1R or GIPR expression plasmids together with a cAMP-responsive element-driven luciferase (CRE-luc) reporter plasmid. A mutated GIP peptide in which Tyr^sup 1^, Ile^sup 7^, Asp^sup 15^, and His^sup 18^ were replaced by His, Thr, Glu, and Ala, respectively, was able to activate both GLP1R and GIPR with moderate potency. Replacing the original Tyr^sup 1^ and/or Ile^sup 7^ in the N-terminal moiety of this mutant peptide allowed full activation of GIPR but not of GLP1R. However, reintroducing Asp^sup 15^ and/or His^sup 18^ in the central α-helical region did not significantly alter the ligand potency. These results suggest that Tyr/His^sup 1^ and Ile/Thr^sup 7^ of GIP/GLP-1 peptides confer differential ligand selectivity toward GIPR and GLP1R.[PUBLICATION ABSTRACT]
Glucagon like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are incretin hormones released in response to food intake and potentiate insulin secretion from pancreatic β cells through their distinct yet related G protein-coupled receptors, GLP1R and GIPR. While GLP-1 and GIP exhibit similarity in their N-terminal sequence and overall α-helical structure, GLP-1 does not bind to GIPR and vice versa. To determine which amino acid residues of these peptide ligands are responsible for specific interaction with their respective receptors, we generated mutant GIP in which several GLP-1-specific amino acid residues were substituted for the original amino acids. The potency of the mutant ligands was examined using HEK293 cells transfected with GLP1R or GIPR expression plasmids together with a cAMP-responsive element-driven luciferase (CRE-luc) reporter plasmid. A mutated GIP peptide in which Tyr1, Ile7, Asp15, and His18were replaced by His, Thr, Glu, and Ala, respectively, was able to activate both GLP1R and GIPR with moderate potency. Replacing the original Tyr1 and/or Ile7 in the Nterminal moiety of this mutant peptide allowed full activation of GIPR but not of GLP1R. However, reintroducing Asp15 and/or His18 in the central α-helical region did not significantly alter the ligand potency. These results suggest that Tyr/His1 and Ile/Thr7 of GIP/GLP-1 peptides confer differential ligand selectivity toward GIPR and GLP1R. KCI Citation Count: 16
Glucagon like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are incretin hormones released in response to food intake and potentiate insulin secretion from pancreatic β cells through their distinct yet related G protein-coupled receptors, GLP1R and GIPR. While GLP-1 and GIP exhibit similarity in their N-terminal sequence and overall α-helical structure, GLP-1 does not bind to GIPR and vice versa. To determine which amino acid residues of these peptide ligands are responsible for specific interaction with their respective receptors, we generated mutant GIP in which several GLP-1-specific amino acid residues were substituted for the original amino acids. The potency of the mutant ligands was examined using HEK293 cells transfected with GLP1R or GIPR expression plasmids together with a cAMP-responsive element-driven luciferase (CRE-luc) reporter plasmid. A mutated GIP peptide in which Tyr 1 , Ile 7 , Asp 15 , and His 18 were replaced by His, Thr, Glu, and Ala, respectively, was able to activate both GLP1R and GIPR with moderate potency. Replacing the original Tyr 1 and/or Ile 7 in the N-terminal moiety of this mutant peptide allowed full activation of GIPR but not of GLP1R. However, reintroducing Asp 15 and/or His 18 in the central α-helical region did not significantly alter the ligand potency. These results suggest that Tyr/His 1 and Ile/Thr 7 of GIP/GLP-1 peptides confer differential ligand selectivity toward GIPR and GLP1R.
Author Seong, Jae Young
Kim, Hee Young
Hwang, Jong-Ik
Choi, Dong Seop
Kim, Sin Gon
Park, Juri
Moon, Mi Jin
Author_xml – sequence: 1
  givenname: Mi Jin
  surname: Moon
  fullname: Moon, Mi Jin
  organization: Graduate School of Medicine, Korea University
– sequence: 2
  givenname: Hee Young
  surname: Kim
  fullname: Kim, Hee Young
  organization: Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine
– sequence: 3
  givenname: Sin Gon
  surname: Kim
  fullname: Kim, Sin Gon
  organization: Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine
– sequence: 4
  givenname: Juri
  surname: Park
  fullname: Park, Juri
  organization: Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine
– sequence: 5
  givenname: Dong Seop
  surname: Choi
  fullname: Choi, Dong Seop
  organization: Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine
– sequence: 6
  givenname: Jong-Ik
  surname: Hwang
  fullname: Hwang, Jong-Ik
  organization: Graduate School of Medicine, Korea University
– sequence: 7
  givenname: Jae Young
  surname: Seong
  fullname: Seong, Jae Young
  email: jyseong@korea.ac.kr
  organization: Graduate School of Medicine, Korea University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/20799012$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001470846$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp9kcFu1DAQQC1URLeFD-CCLC7AITB2YntzrCooK1UCob1bXnsSuZvawc6C9lv4WZxmAQkJDuOZw3szI88FOQsxICHPGbxlAOpdLq9oK2AwB1TiEVkBZ23FoOZnZMWAyWrdqPU5ucj5DoApyddPyDkH1bbA-Ir82B4ToyY4uhlQ0djRfjjYmLFyOGJwGCbqQz4MPsQpxdFbOsbhOOI4eYf09c3m8xtqY-gwUee7korhzUAH389dMw5oJ__NT0c6xe8mOVqUh4HzINPHUA1-j_TUsWI0oS11TPkpedyZIeOzU74k2w_vt9cfq9tPN5vrq9vK8kaJSomuZsw2yjZdKx0oKUzr6t3aAqCRDBw3UnErwKJT0oi6loLZXYPdrnG8viSvlrYhdXpvvY7GP-Q-6n3SV1-2G604yJl8uZBjil8PmCd9Fw8plN20alrJZC1YgV6coMPuHp0ek7836ah__XkB2ALYFHNO2P1GGOj5rnq5qy43nQO0KI76y7F-MpOPYUrGD_81-WLmMiX0mP7s_G_pJ_cMtwM
CitedBy_id crossref_primary_10_1016_j_molmet_2019_09_010
crossref_primary_10_1530_EJE_16_0831
crossref_primary_10_2147_DDDT_S358989
crossref_primary_10_1530_JME_13_0137
crossref_primary_10_1074_jbc_M114_612606
crossref_primary_10_1371_journal_pone_0065420
crossref_primary_10_1093_molbev_mst031
crossref_primary_10_2967_jnumed_113_133744
crossref_primary_10_3390_jcm10071377
crossref_primary_10_1016_j_mce_2018_10_011
crossref_primary_10_1074_jbc_M111_276808
crossref_primary_10_1016_j_jconrel_2016_03_017
crossref_primary_10_3803_EnM_2014_29_3_320
crossref_primary_10_1016_j_pharmthera_2012_05_009
crossref_primary_10_4062_biomolther_2016_199
Cites_doi 10.1074/jbc.270.24.14394
10.1053/j.gastro.2009.09.004
10.1073/pnas.0706404104
10.1074/jbc.M109.033829
10.1073/pnas.84.10.3434
10.1124/mol.109.060111
10.1210/jc.76.4.912
10.1016/0167-0115(96)00019-5
10.1016/j.ygcen.2006.12.013
10.1210/en.2008-1679
10.1210/endo-119-4-1467
10.1210/er.21.6.619
10.1021/bi010902s
10.1053/j.gastro.2007.03.054
10.1038/sj.bjp.0705453
10.2337/diabetes.51.3.652
10.1111/j.1432-1033.1994.1151b.x
10.1016/j.lfs.2004.03.024
10.1210/edrv-16-3-390
10.1016/S0021-9258(17)37366-0
10.1016/S0167-4838(01)00181-9
10.1016/S0021-9258(19)36565-2
ContentType Journal Article
Copyright The Korean Society for Molecular and Cellular Biology and Springer Netherlands 2010
Copyright_xml – notice: The Korean Society for Molecular and Cellular Biology and Springer Netherlands 2010
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88A
88E
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
BVBZV
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
ACYCR
DOI 10.1007/s10059-010-0100-5
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
AUTh Library subscriptions: ProQuest Central
Natural Science Collection
East & South Asia Database
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Korean Citation Index
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
East & South Asia Database
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
DatabaseTitleList MEDLINE
ProQuest Central Student


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 0219-1032
EndPage 154
ExternalDocumentID oai_kci_go_kr_ARTI_72062
2131092391
20799012
10_1007_s10059_010_0100_5
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.UV
0R~
0VY
123
1N0
29M
2VQ
2WC
30V
3V.
4.4
408
40D
53G
5VS
67N
67Z
7X7
88A
88E
8AO
8FE
8FH
8FI
8FJ
8TC
8UJ
95.
9ZL
AALRI
AARHV
AAXUO
AAYZH
ABDBF
ABMNI
ABTEG
ABUWG
ACBXY
ACGFO
ACGFS
ACPRK
ACREN
ADBBV
ADINQ
ADKPE
ADVLN
AENEX
AFGCZ
AFJKZ
AFKRA
AFLOW
AGJBK
AHBYD
AHMBA
AHSBF
AITUG
AKRWK
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMRAJ
AMTXH
AOIJS
ASPBG
AVWKF
AZFZN
BBNVY
BENPR
BGNMA
BHPHI
BPHCQ
BVBZV
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DU5
E3Z
EAD
EAP
EBS
EJD
EMK
EMOBN
EST
ESX
F5P
FDB
FYUFA
GROUPED_DOAJ
GX1
H13
HCIFZ
HF~
HG6
HH5
HMCUK
HMJXF
HYE
HZ~
I09
I0C
IXC
I~X
JDI
KDC
KOV
KVFHK
LAS
LK8
M0L
M1P
M41
M4Y
M7P
MA-
NU0
OK1
P2P
PQQKQ
PROAC
PSQYO
Q2X
R9I
ROL
RPM
RSV
S1Z
S27
S3A
S3B
SBL
SDH
SJN
SOJ
SV3
T13
TSK
TUS
U2A
UKHRP
VC2
WK8
Z45
~A9
AAYWO
AAYXX
ABFSG
ACSTC
ACVFH
ADCNI
AEUPX
AEZWR
AFHIU
AFPUW
AHWEU
AIGII
AIXLP
AKBMS
AKYEP
APXCP
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
AZQEC
DWQXO
GNUQQ
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
ABJNI
ACYCR
AFNRJ
EBC
EBD
ID FETCH-LOGICAL-c2475-75f311c47c4f96d0765a9d3b8c00ea610d2a672c50ced76a533651cb4efb4d23
IEDL.DBID U2A
ISSN 1016-8478
IngestDate Fri Apr 19 03:47:28 EDT 2024
Wed Aug 13 05:31:49 EDT 2025
Thu Jan 02 22:35:39 EST 2025
Thu Apr 24 23:04:53 EDT 2025
Tue Jul 01 03:43:04 EDT 2025
Fri Feb 21 02:42:18 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords GPCR
ligand selectivity
GLP-1
insulin
pancreas
GIP
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2475-75f311c47c4f96d0765a9d3b8c00ea610d2a672c50ced76a533651cb4efb4d23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
G704-000079.2010.30.2.002
PMID 20799012
PQID 749616351
PQPubID 54653
PageCount 6
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_72062
proquest_journals_749616351
pubmed_primary_20799012
crossref_primary_10_1007_s10059_010_0100_5
crossref_citationtrail_10_1007_s10059_010_0100_5
springer_journals_10_1007_s10059_010_0100_5
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20100800
2010-08-00
2010-Aug
20100801
2010-08
PublicationDateYYYYMMDD 2010-08-01
PublicationDate_xml – month: 8
  year: 2010
  text: 20100800
PublicationDecade 2010
PublicationPlace Springer
PublicationPlace_xml – name: Springer
– name: United States
– name: Seoul
PublicationSubtitle Official Publication of the Korean Society for Molecular and Cellular Biology
PublicationTitle Molecules and cells
PublicationTitleAbbrev Mol Cells
PublicationTitleAlternate Mol Cells
PublicationYear 2010
Publisher Korean Society for Molecular and Cellular Biology
한국분자세포생물학회
Publisher_xml – name: Korean Society for Molecular and Cellular Biology
– name: 한국분자세포생물학회
References Cho, Acharjee, Moon, Oh, Vaudry, Kwon, Seong (CR4) 2007; 153
Gallwitz, Witt, Paetzold, Morys-Wortmann, Zimmermann, Eckart, Folsch, Schmidt (CR7) 1994; 225
Adelhorst, Hedegaard, Knudsen, Kirk (CR1) 1994; 269
Neidigh, Fesinmeyer, Prickett, Andersen (CR17) 2001; 40
Göke, Fehmann, Linn, Schmidt, Krause, Eng, Goke (CR9) 1993; 268
Baggio, Drucker (CR3) 2007; 132
Hinke, Manhart, Pamir, Demuth, W. Gelling, Pederson, McIntosh (CR10) 2001; 1547
Nauck, Bartels, Orskov, Ebert, Creutzfeldt (CR16) 1993; 76
Lee, Tsunekawa, Moon, Um, Hwang, Osugi, Otaki, Sunakawa, Kim, Vaudry (CR14) 2009; 150
Underwood, Garibay, Knudsen, Hastrup, Peters, Rudolph, Reedtz-Runge (CR21) 2010; 285
Drucker, Philippe, Mojsov, Chick, Habener (CR5) 1987; 84
Hinke, Gelling, Pederson, Manhart, Nian, Demuth, McIntosh (CR11) 2002; 51
Fehmann, Goke, Goke (CR6) 1995; 16
Orskov, Holst, Knuhtsen, Baldissera, Poulsen, Nielsen (CR18) 1986; 119
Holtmann, Hadac, Miller (CR13) 1995; 270
Parthier, Kleinschmidt, Neumann, Rudolph, Manhart, Schlenzig, Fanghanel, Rahfeld, Demuth, Stubbs (CR19) 2007; 104
Hinke, Manhart, Speck, Pederson, Demuth, McIntosh (CR12) 2004; 75
Sherwood, Krueckl, McRory (CR20) 2000; 21
Yaqub, Tikhonova, Lattig, Magnan, Laval, Escrieut, Boulegue, Hewage, Fourmy (CR22) 2010; 77
Al-Sabah, Donnelly (CR2) 2003; 140
Maida, Hansotia, Longuet, Seino, Drucker (CR15) 2009; 137
Gallwitz, Witt, Morys-Wortmann, Folsch, Schmidt (CR8) 1996; 63
Hinke (10.1007/s10059-010-0100-5_bib11) 2002; 51
Maida (10.1007/s10059-010-0100-5_bib15) 2009; 137
Drucker (10.1007/s10059-010-0100-5_bib5) 1987; 84
Holtmann (10.1007/s10059-010-0100-5_bib13) 1995; 270
Nauck (10.1007/s10059-010-0100-5_bib16) 1993; 76
Cho (10.1007/s10059-010-0100-5_bib4) 2007; 153
Parthier (10.1007/s10059-010-0100-5_bib19) 2007; 104
Sherwood (10.1007/s10059-010-0100-5_bib20) 2000; 21
Orskov (10.1007/s10059-010-0100-5_bib18) 1986; 119
Fehmann (10.1007/s10059-010-0100-5_bib6) 1995; 16
Gallwitz (10.1007/s10059-010-0100-5_bib7) 1994; 225
Underwood (10.1007/s10059-010-0100-5_bib21) 2010; 285
Hinke (10.1007/s10059-010-0100-5_bib10) 2001; 1547
Gallwitz (10.1007/s10059-010-0100-5_bib8) 1996; 63
Yaqub (10.1007/s10059-010-0100-5_bib22) 2010; 77
Lee (10.1007/s10059-010-0100-5_bib14) 2009; 150
Adelhorst (10.1007/s10059-010-0100-5_bib1) 1994; 269
Göke (10.1007/s10059-010-0100-5_bib9) 1993; 268
Hinke (10.1007/s10059-010-0100-5_bib12) 2004; 75
Baggio (10.1007/s10059-010-0100-5_bib3) 2007; 132
Al-Sabah (10.1007/s10059-010-0100-5_bib2) 2003; 140
Neidigh (10.1007/s10059-010-0100-5_bib17) 2001; 40
References_xml – volume: 1547
  start-page: 143
  year: 2001
  end-page: 155
  ident: CR10
  article-title: Identification of a bioactive domain in the amino-terminus of glucose-dependent insulinotropic polypeptide (GIP)
  publication-title: Biochim. Biophys. Acta
– volume: 75
  start-page: 1857
  year: 2004
  end-page: 1870
  ident: CR12
  article-title: In depth analysis of the N-terminal bioactive domain of gastric inhibitory polypeptide
  publication-title: Life Sci.
– volume: 270
  start-page: 14394
  year: 1995
  end-page: 14398
  ident: CR13
  article-title: Critical contributions of amino-terminal extracellular domains in agonist binding and activation of secretin and vasoactive intestinal polypeptide receptors. Studies of chimeric receptors
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.270.24.14394
– volume: 137
  start-page: 2146
  year: 2009
  end-page: 2157
  ident: CR15
  article-title: Differential importance of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide 1 receptor signaling for beta cell survival in mice
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2009.09.004
– volume: 104
  start-page: 13942
  year: 2007
  end-page: 13947
  ident: CR19
  article-title: Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.0706404104
– volume: 285
  start-page: 723
  year: 2010
  end-page: 730
  ident: CR21
  article-title: Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M109.033829
– volume: 84
  start-page: 3434
  year: 1987
  end-page: 3438
  ident: CR5
  article-title: Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.84.10.3434
– volume: 77
  start-page: 547
  year: 2010
  end-page: 558
  ident: CR22
  article-title: Identification of determinants of glucose-dependent insulinotropic polypeptide receptor that interact with N-terminal biologically active region of the natural ligand
  publication-title: Mol. Pharmacol.
  doi: 10.1124/mol.109.060111
– volume: 16
  start-page: 390
  year: 1995
  end-page: 410
  ident: CR6
  article-title: Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide
  publication-title: Endocr. Rev.
– volume: 76
  start-page: 912
  year: 1993
  end-page: 917
  ident: CR16
  article-title: Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jc.76.4.912
– volume: 63
  start-page: 17
  year: 1996
  end-page: 22
  ident: CR8
  article-title: GLP-1/GIP chimeric peptides define the structural requirements for specific ligand-receptor interaction of GLP-1
  publication-title: Regul. Pept.
  doi: 10.1016/0167-0115(96)00019-5
– volume: 268
  start-page: 19650
  year: 1993
  end-page: 19655
  ident: CR9
  article-title: Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells
  publication-title: J. Biol. Chem.
– volume: 153
  start-page: 98
  year: 2007
  end-page: 107
  ident: CR4
  article-title: Molecular evolution of neuropeptide receptors with regard to maintaining high affinity to their authentic ligands
  publication-title: Gen. Comp. Endocrinol.
  doi: 10.1016/j.ygcen.2006.12.013
– volume: 150
  start-page: 2837
  year: 2009
  end-page: 2846
  ident: CR14
  article-title: Molecular evolution of multiple forms of kisspeptins and GPR54 receptors in vertebrates
  publication-title: Endocrinology
  doi: 10.1210/en.2008-1679
– volume: 269
  start-page: 6275
  year: 1994
  end-page: 6278
  ident: CR1
  article-title: Structure-activity studies of glucagon-like peptide-1
  publication-title: J. Biol. Chem.
– volume: 119
  start-page: 1467
  year: 1986
  end-page: 1475
  ident: CR18
  article-title: Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas
  publication-title: Endocrinology
  doi: 10.1210/endo-119-4-1467
– volume: 21
  start-page: 619
  year: 2000
  end-page: 670
  ident: CR20
  article-title: The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily
  publication-title: Endocr. Rev.
  doi: 10.1210/er.21.6.619
– volume: 40
  start-page: 13188
  year: 2001
  end-page: 13200
  ident: CR17
  article-title: Exendin-4 and glucagon-like-peptide-1: NMR structural comparisons in the solution and micelle-associated states
  publication-title: Biochemistry
  doi: 10.1021/bi010902s
– volume: 132
  start-page: 2131
  year: 2007
  end-page: 2157
  ident: CR3
  article-title: Biology of incretins: GLP-1 and GIP
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2007.03.054
– volume: 140
  start-page: 339
  year: 2003
  end-page: 346
  ident: CR2
  article-title: A model for receptor-peptide binding at the glucagon-like peptide-1 (GLP-1) receptor through the analysis of truncated ligands and receptors
  publication-title: Br. J. Pharmacol.
  doi: 10.1038/sj.bjp.0705453
– volume: 51
  start-page: 652
  year: 2002
  end-page: 661
  ident: CR11
  article-title: Dipeptidyl peptidase IV-resistant [D-Ala(2)]glucose-dependent insulinotropic polypeptide (GIP) improves glucose tolerance in normal and obese diabetic rats
  publication-title: Diabetes
  doi: 10.2337/diabetes.51.3.652
– volume: 225
  start-page: 1151
  year: 1994
  end-page: 1156
  ident: CR7
  article-title: Structure/activity characterization of glucagon-like peptide-1
  publication-title: Eur. J. Biochem.
  doi: 10.1111/j.1432-1033.1994.1151b.x
– volume: 84
  start-page: 3434
  year: 1987
  ident: 10.1007/s10059-010-0100-5_bib5
  article-title: Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.84.10.3434
– volume: 75
  start-page: 1857
  year: 2004
  ident: 10.1007/s10059-010-0100-5_bib12
  article-title: In depth analysis of the N-terminal bioactive domain of gastric inhibitory polypeptide
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2004.03.024
– volume: 16
  start-page: 390
  year: 1995
  ident: 10.1007/s10059-010-0100-5_bib6
  article-title: Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide
  publication-title: Endocr. Rev
  doi: 10.1210/edrv-16-3-390
– volume: 140
  start-page: 339
  year: 2003
  ident: 10.1007/s10059-010-0100-5_bib2
  article-title: A model for receptor-peptide binding at the glucagon-like peptide-1 (GLP-1) receptor through the analysis of truncated ligands and receptors
  publication-title: Br. J. Pharmacol
  doi: 10.1038/sj.bjp.0705453
– volume: 153
  start-page: 98
  year: 2007
  ident: 10.1007/s10059-010-0100-5_bib4
  article-title: Molecular evolution of neuropeptide receptors with regard to maintaining high affinity to their authentic ligands
  publication-title: Gen. Comp. Endocrinol
  doi: 10.1016/j.ygcen.2006.12.013
– volume: 63
  start-page: 17
  year: 1996
  ident: 10.1007/s10059-010-0100-5_bib8
  article-title: GLP-1/GIP chimeric peptides define the structural requirements for specific ligand-receptor interaction of GLP-1. Regul
  publication-title: Pept
  doi: 10.1016/0167-0115(96)00019-5
– volume: 40
  start-page: 13188
  year: 2001
  ident: 10.1007/s10059-010-0100-5_bib17
  article-title: Exendin-4 and glucagon-like-peptide-1: NMR structural comparisons in the solution and micelle-associated states
  publication-title: Biochemistry
  doi: 10.1021/bi010902s
– volume: 285
  start-page: 723
  year: 2010
  ident: 10.1007/s10059-010-0100-5_bib21
  article-title: Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor
  publication-title: J. Biol. Chem
  doi: 10.1074/jbc.M109.033829
– volume: 269
  start-page: 6275
  year: 1994
  ident: 10.1007/s10059-010-0100-5_bib1
  article-title: Structure-activity studies of glucagon-like peptide-1
  publication-title: J. Biol. Chem
  doi: 10.1016/S0021-9258(17)37366-0
– volume: 132
  start-page: 2131
  year: 2007
  ident: 10.1007/s10059-010-0100-5_bib3
  article-title: Biology of incretins: GLP-1 and GIP
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2007.03.054
– volume: 137
  start-page: 2146
  year: 2009
  ident: 10.1007/s10059-010-0100-5_bib15
  article-title: Differential importance of glucose-dependent insulino- tropic polypeptide vs glucagon-like peptide 1 receptor signaling for beta cell survival in mice
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2009.09.004
– volume: 76
  start-page: 912
  year: 1993
  ident: 10.1007/s10059-010-0100-5_bib16
  article-title: Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations
  publication-title: J. Clin. Endocrinol. Metab
– volume: 225
  start-page: 1151
  year: 1994
  ident: 10.1007/s10059-010-0100-5_bib7
  article-title: Structure/activity characterization of glucagon-like peptide-1
  publication-title: Eur. J. Biochem
  doi: 10.1111/j.1432-1033.1994.1151b.x
– volume: 1547
  start-page: 143
  year: 2001
  ident: 10.1007/s10059-010-0100-5_bib10
  article-title: Identification of a bioactive domain in the amino-terminus of glucose-dependent insulino- tropic polypeptide (GIP)
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/S0167-4838(01)00181-9
– volume: 104
  start-page: 13942
  year: 2007
  ident: 10.1007/s10059-010-0100-5_bib19
  article-title: Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.0706404104
– volume: 150
  start-page: 2837
  year: 2009
  ident: 10.1007/s10059-010-0100-5_bib14
  article-title: Molecular evolution of multiple forms of kisspeptins and GPR54 receptors in vertebrates
  publication-title: Endocrinology
  doi: 10.1210/en.2008-1679
– volume: 51
  start-page: 652
  year: 2002
  ident: 10.1007/s10059-010-0100-5_bib11
  article-title: Dipeptidyl peptidase IV-resistant [D-Ala(2)]glucose-dependent insulinotropic polypeptide (GIP) improves glucose tolerance in normal and obese diabetic rats
  publication-title: Diabetes
  doi: 10.2337/diabetes.51.3.652
– volume: 268
  start-page: 19650
  year: 1993
  ident: 10.1007/s10059-010-0100-5_bib9
  article-title: Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells
  publication-title: J. Biol. Chem
  doi: 10.1016/S0021-9258(19)36565-2
– volume: 21
  start-page: 619
  year: 2000
  ident: 10.1007/s10059-010-0100-5_bib20
  article-title: The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily
  publication-title: Endocr. Rev
– volume: 119
  start-page: 1467
  year: 1986
  ident: 10.1007/s10059-010-0100-5_bib18
  article-title: Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas
  publication-title: Endocrinology
  doi: 10.1210/endo-119-4-1467
– volume: 77
  start-page: 547
  year: 2010
  ident: 10.1007/s10059-010-0100-5_bib22
  article-title: Identification of determinants of glucose-dependent insulinotropic polypeptide receptor that interact with N-terminal biologically active region of the natural ligand
  publication-title: Mol. Pharmacol
  doi: 10.1124/mol.109.060111
– volume: 270
  start-page: 14394
  year: 1995
  ident: 10.1007/s10059-010-0100-5_bib13
  article-title: Critical contributions of amino-terminal extracellular domains in agonist binding and activation of secretin and vasoactive intestinal polypeptide receptors. Studies of chimeric receptors
  publication-title: J. Biol. Chem
  doi: 10.1074/jbc.270.24.14394
SSID ssj0017628
ssib049006238
ssib053376808
Score 1.8642887
Snippet Glucagon like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are incretin hormones released in response to food intake and potentiate...
SourceID nrf
proquest
pubmed
crossref
springer
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 149
SubjectTerms Amino Acid Sequence
Animals
Biochemistry
Biomedical and Life Sciences
Biomedicine
Biotechnology
Cell Biology
Exenatide
Gastric Inhibitory Polypeptide - chemistry
Gastric Inhibitory Polypeptide - metabolism
Glucagon-Like Peptide-1 Receptor
Humans
Isoleucine - metabolism
Life Sciences
Ligands
Molecular Sequence Data
Peptides - chemistry
Rats
Receptors, Gastrointestinal Hormone - metabolism
Receptors, Glucagon - chemistry
Receptors, Glucagon - metabolism
Recombinant Proteins - chemistry
Recombinant Proteins - metabolism
Sequence Alignment
Structure-Activity Relationship
Tyrosine - metabolism
Venoms - chemistry
생물학
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZoERKXivLcliIfOPCQRezY8eaEEKJ0OSAOi7Q3K35ktdooXrLpob-lf5ax42SFgB6i-BDbkWcy_px5fAi9ntOqlFoYMtfCEs50TrTQlDBWcpNzG5ISQrTF9-LqJ_-2EqsUm7NPYZWjTYyG2noT_pF_kLwsADsI-nH3iwTSqOBcTQwaR-h-rFwG6ixX027Ky5AgeFAvADYyEE1MTgawA0OmHC0IGOn56PQcMusAd5DoKYYmEX9sW0dtV_8Lkf7lTY2b1OUjdJLQJf40qMMpuufax-jBwDd58wTdLm86iqvW4kXjJPY1ThHrZOTC7XEKTvd953cbg3e-gZMq2BXr8Juvix9vsYk5gnhkVgEL0eBmsw6j7iOpTqSjwH2Mx8XQJU4YJqrWviXNZutwGpFQDAYX2r7bP0XLyy_Lz1cksTMQw7gURIo6p9RwaXhdFjaThahKm-u5yTJXASqzrCokMyIzzsqiguUvBDWau1pzy_Jn6Lj1rXuBMK9CETUqNCsE56wua6pzowE51DwDuDZD2bj2yqTK5YFAo1GHmstBXApEFa5MiRl6N3XZDWU77noYg0DV1mxUKLYd7muvtp2CI8VCSQZaNEPno7RV-sj3alLJGXo-KMA0F8tkcDhCv_ejRhz6_fdFzu6c5Rw9HEIXQvThS3Tcd9fuAhBRr19Fvf8Npw4Bcw
  priority: 102
  providerName: ProQuest
Title Tyr1 and Ile7 of glucose-dependent insulinotropic polypeptide (GIP) confer differential ligand selectivity toward GIP and glucagon-like peptide-1 receptors
URI https://link.springer.com/article/10.1007/s10059-010-0100-5
https://www.ncbi.nlm.nih.gov/pubmed/20799012
https://www.proquest.com/docview/749616351
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001470846
Volume 30
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Molecules and Cells, 2010, 30(2), , pp.149-154
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Li9swEBbNLoVeSt-bbht06KEPBJasR3zclt1uCg2hZCE3YclyCDF2cNzD_pb-2Y5kK2npttCDsQ0aSUgzo0_MC6E3U5pnyghLpkYUhDOTEiMMJYxl3Ka88EEJ3ttiLq9v-JeVWA1x3Pvo7R5NkkFT_xLsBlCABOMtfBIxQqcCru5eGm_YRWQinvmwwCNTAZxRvrzEwbQA0t_Hx1FJQDVPo6nzriF-O6xGdVvehUP_sKGGo-nqEXo4YEp80TPBY3TP1U_Q_b7K5O1T9GN521Kc1wWeVU7hpsSDnzqJFXA7PLikN13b7DYW75oK7qegTQqH336eLd5hGyIDcaynAnqhwtVm7Xvdh1I6oQgF7oIXLgaSMKAfKF83Nak2W4eHHgnFoGbhu2n3z9Dy6nL56ZoMNRmIZVwJokSZUmq5srzMZJEoKfKsSM3UJonLAYsVLJeKWZFYVyiZw_JLQa3hrjS8YOlzdFI3tTtDmOc-dRoVhknBOSuzkprUGsALJU8ApI1REtde2yFfuS-bUeljpmW_XRq2yj-JFmP0_kCy65N1_Ksxhg3VW7vRPsW2f68bvW01XCRmWjHgojE6j7utB9Hea8UzCSBWwARf9AxwGIslypsZge5D5Igj3V8n8vK_Wp-jB70Dg_dBfIVOuva7ew24qDMTNFIrNUGnHy_ni2_wN198nQTZ-Am8-wG3
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jj9MwFLaGjhBcEDtlWHwAiUUWsWvHzQEhlhkaZqhGqEhzs-IlVdUoKWkQ6m_hL_AjeU7iVgiY2xyi5JAXR3nPz5_zlg-hJ2OaJVILQ8ZaWMKZHhEtNCWMJdyMuPVFCT7bYhpPvvJPZ-JsD_0KtTA-rTL4xNZR28r4f-SvJE9iwA6Cvll9I540ygdXA4NGZxXHbvMDdmzr1-kHUO9Txo4OZ-8npCcVIIZxKYgU-YhSw6XheRJb2MaLLLEjPTZR5DIAE5ZlsWRGRMZZGWcAh2JBjeYu19z6Ngfg8Pe5r2cdoP13h9PTL8F-eeIrEnf2DKLSM1tsoxrgeLrSPBoTWBXGIcralfIB0CFtaBouifhjnbxU1vm_IPBf4dt2VTy6jq71cBa_7ezvBtpz5U10uSO43NxCP2ebmuKstDgtnMRVjvsUeRLIdxvcZ8NXTV2tFgavqgK2xuDIrMPPPqanz7FpixJxoHIBl1TgYjH3T123LD4t_wVu2gRgDCLtgH6gbF6VpFgsHe6fSCgGDw_XVb2-jWYXobk7aFBWpbuHMM981zYqNIsF5yxPcqpHRgNUyXkE-HCIovDtlelbpXvGjkLtmjx7dSlQlT8iJYboxVZk1fUJOe9mDApVS7NQvru3P88rtawV7GFSJRlY0RAdBG2r3qus1XYODNHdzgC2Y7FI-ggnyL0MFrGT---L3D93lMfoymT2-USdpNPjA3S1y5vwqY8P0KCpv7uHAMca_aifBRipC553vwGajz6C
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Jj9MwFLaYQSAuiJ0yLD5wYJE1seOlOY6AMgU0mkNHmpsVb1XVKKnScJjfwp_lOYlbEAMShyg-eJP9_PxZb_kQej2lZaGMsGRqhCOcmZwYYShhrOA25y4GJURvizN5esG_XIrLked0m7zdk0lyiGmIWZrq7njjwvEvgW8AC0hvyIUiEQfoJmhjGgX9gp0kgeJFDBHcCxhAGxWpJnZmBtAEQ6wclQTU9DSZPa8b4reL66Buw3WY9A97an9Nze6huyO-xCeDQNxHN3z9AN0aGCevHqIfi6uW4rJ2eF55hZuAR591kthwOzy6pzdd22xWFm-aCt6qoFmcx28-z8_fYttHCeLErQI6osLVahl73fa0Oj0hBe56j1wMTfoB40DlsqlJtVp7PPZIKAaVC-Wm3T5Ci9mnxYdTMvIzEMu4EkSJkFNqubI8FNJlSoqycLmZ2izzJeAyx0qpmBWZ9U7JEpZfCmoN98Fwx_LH6LBuav8UYV7GNGpUGCYF5ywUgZrcGsAOgWcA2CYoS2uv7Zi7PFJoVHqfdTlul4atil-mxQS92zXZDIk7_lUZw4bqtV3pmG47_peNXrcaHhVzrRhI0QQdpd3W4zHfasULCYBWwASfDAKwG4tlKpocod37JBH7dn-dyLP_qv0K3T7_ONPf5mdfj9Cdwa8huiY-R4dd-92_ALjUmZf9kfgJ3IwFWQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tyr1+and+Ile7+of+glucose-dependent+insulinotropic+polypeptide+%28GIP%29+confer+differential+ligand+selectivity+toward+GIP+and+glucagon-like+peptide-1+receptors&rft.jtitle=Molecules+and+cells&rft.au=Moon%2C+Mi+Jin&rft.au=Kim%2C+Hee+Young&rft.au=Kim%2C+Sin+Gon&rft.au=Park%2C+Juri&rft.date=2010-08-01&rft.pub=Korean+Society+for+Molecular+and+Cellular+Biology&rft.issn=1016-8478&rft.eissn=0219-1032&rft.volume=30&rft.issue=2&rft.spage=149&rft.epage=154&rft_id=info:doi/10.1007%2Fs10059-010-0100-5&rft.externalDocID=10_1007_s10059_010_0100_5
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1016-8478&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1016-8478&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1016-8478&client=summon